Molina Healthcare (MOH) PT Lowered to $124 by Goldman Sachs Following Q4 Earnings Miss

Molina Healthcare Inc. (NYSE:MOH) is one of the most undervalued mid cap stocks to buy now. On February 12, Goldman Sachs lowered its price target on Molina Healthcare to $124 from $167 while keeping a Neutral rating. This adjustment was made following the company’s Q4 2025 earnings miss. The firm noted that the return profiles for even the strongest operators in low-margin, government-priced cyclical businesses can diminish rapidly during a broad-based downturn. Goldman Sachs expects these challenges to ...